ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. - Wikidata - awgldk - TriplyDB

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.

http://www.wikidata.org/entity/Q33346972

about

Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9.Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer.GOLPH2 expression may serve as diagnostic marker in seminomas.A disintegrin and metalloproteinase 9 is involved in ectodomain shedding of receptor-binding cancer antigen expressed on SiSo cells.Gene expression profiles of the NCI-60 human tumor cell lines define molecular interaction networks governing cell migration processes GOLPH2 expression in renal cell cancer ADAM9 up-regulates N-cadherin via miR-218 suppression in lung adenocarcinoma cells Graded activation of the MEK1/MT1-MMP axis determines renal epithelial cell tumor phenotype.miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade Gliomas Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis.Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.High expression of a disintegrin and metalloproteinase-9 predicts a shortened survival time in completely resected stage I non-small cell lung cancer.ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell death.MicroRNA-154/ADAM9 axis inhibits the proliferation, migration and invasion of breast cancer cells.Overexpression of ADAM9 in oral squamous cell carcinoma.Loss of ADAM9 expression impairs β1 integrin endocytosis, focal adhesion formation and cancer cell migration.Sorting nexin 9 (SNX9) regulates levels of the transmembrane disintegrin and metalloproteinase (ADAM)-9 at the cell surface.

P2860

Q27333563-50BD8CA1-0168-4157-81E0-13FB5B2B9A26 Q33491820-1ACAD0A0-A4DC-41C4-926E-0913BEEC57B5 Q33534479-A7468FF2-8641-416A-A610-1C33F5A47356 Q34079881-E680F890-8B83-44BB-BAC7-08892311A237 Q34263230-8FB84A92-3E37-45DE-97B7-0F2B5BE9BF12 Q34600429-96F459B7-9358-4FF5-9E66-F777369331BC Q35140315-DEAC1E4F-2826-45D1-9F92-68A2146B5E9D Q35562923-13202EC7-EBE8-420A-946A-AB466D73C645 Q35921263-B93D5985-4DD9-4973-A01A-78925FE6AD1A Q37286187-93B664F7-AD2F-4556-BDB3-00D8FFFB0412 Q38758627-A38A99B8-451D-4879-A6B2-2F56804B19E3 Q40149856-46C31EA0-CA13-416E-9CB2-C3CE5778A705 Q42149506-28DBA2AC-EE9B-4247-B754-30F3E08B1106 Q46238472-CBB4A59A-B116-4B20-BA1C-6B8358F9E547 Q47143534-7E543657-EA37-4713-9100-8623AFFE2012 Q47162764-08FE5ABB-A633-413F-BCE3-C44EF021CDB8 Q47590431-D74BC951-0620-4AA5-A382-E0BFA60C1489 Q52603837-72F7457B-F71C-47C2-8745-294FB2139A40

P2860

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.

http://www.wikidata.org/entity/Q33346972

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.

@ast

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.

@en

type

label

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.

@ast

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.

@en

prefLabel

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.

@ast

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.

@en

P1433

Q33346972-161A6C6B-D829-48EE-A504-0E34BA6A0758

P1476

Q33346972-65A7BD0D-6384-45EF-B235-E9D630192408

P2093

Q33346972-0452B58A-69E1-4FE1-8751-5B76FDD5E45C

Q33346972-975EA370-C61C-4310-BCB5-A064366D5DF9

Q33346972-C5C34B4B-9538-400E-A673-9633D2214B2F

Q33346972-CA56AA81-9520-46A1-A25B-09303D1B61D5

Q33346972-CCB28084-A769-45F2-BB07-DEC883879546

Q33346972-D42384EA-9F8A-41BB-9625-1E16D696A39F

Q33346972-E8125AE9-D5A9-427C-B60B-137F5B54F86A

Q33346972-EF19D368-0A8E-4407-A2E0-046639FB4B6F

Q33346972-F4079960-483D-48CF-BAFC-C87CDEDAB1B9

P2860

Q33346972-00557A94-9F21-4D9C-A6C9-93026D15C239

Q33346972-00B8E785-4D52-467A-8350-B41689E38D27

Q33346972-0B32D5A8-31B1-412C-9A46-4EA88817AD9E

Q33346972-1D5E2B4A-3170-4C5A-8FB2-5FAE1E10B02E

Q33346972-26BE4F39-710A-4AEB-96BA-E4BB6B796B3F

Q33346972-272771F4-F184-4403-9184-5399E5FB6486

Q33346972-377A7D9C-B34A-4549-9259-183AF7445EA6

Q33346972-399E0BC8-2D5C-45E7-AC07-5A24817655A0

Q33346972-3CDA5719-9BC8-4DE4-8607-1ECE2AB03163

Q33346972-3F8748F4-F4D6-4BD7-96A9-D11705D31C2B

P2888

Q33346972-408281D4-0386-4DFA-BC7B-11F474962097

P304

Q33346972-9C16C7A8-BC7E-467D-92C4-E005AD7DC482

P31

Q33346972-FF643BA7-7DCB-42B3-BAB1-F533B946D539

P356

Q33346972-367C9BE1-B48C-41AB-980A-23FB445C56BE

P407

Q33346972-A942416E-E3AD-4EBA-AB61-1A296AC4CD02

P478

Q33346972-FD6135B7-B125-4D8E-9795-43DD21278772

P50

Q33346972-B76447FE-E6DB-4E40-B167-1F0262F54885

P577

Q33346972-D4941707-886E-4EA0-978B-1CBF79B4FE1A

P5875

Q33346972-8FAFABF2-CE20-4198-9A09-0AEDC4B20F61

P6179

Q33346972-3993335E-A76F-439C-A454-AA28F9476D04

P698

Q33346972-AD5EC41B-3CB8-48B0-9CE8-477E5127D522

P932

Q33346972-8169747F-B330-4CB7-B893-35815250A5CC

P356

1471-2407-8-179

P1433

P1476

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.

@en

P2093

Angelika Tölle

http://www.w3.org/2001/XMLSchema#string

Florian R Fritzsche

http://www.w3.org/2001/XMLSchema#string

Glen Kristiansen

http://www.w3.org/2001/XMLSchema#string

Ilka Kristiansen

http://www.w3.org/2001/XMLSchema#string

Kirsten Wassermann

http://www.w3.org/2001/XMLSchema#string

Klaus Jung

http://www.w3.org/2001/XMLSchema#string

Manfred Johannsen

http://www.w3.org/2001/XMLSchema#string

Michael Lein

http://www.w3.org/2001/XMLSchema#string

Monika Jung

http://www.w3.org/2001/XMLSchema#string

P2860

The RIN: an RNA integrity number for assigning integrity values to RNA measurements

Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity

MDC-9 (ADAM-9/Meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin

ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands

The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins

Oxidative stress induces ADAM9 protein expression in human prostate cancer cells

A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma

ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions

P2888

1471-2407-8-179

P304

179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-8-179

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5272524

http://www.w3.org/2001/XMLSchema#string

P6179

1023760529

http://www.w3.org/2001/XMLSchema#string

P698

18582378

http://www.w3.org/2001/XMLSchema#string

P932

2442841

http://www.w3.org/2001/XMLSchema#string